Association of hypertension with helicobacter pylori: A systematic review and meta‑analysis
Authors:
Open Access
- 19 May 2022
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (5) , e0268686
Abstract
Background and aims: The number of hypertensive population rises year by year recently, and their age becomes more youthful. For a long time, hypertension has long been regarded as a multi-factorial disease. In addition to smoking, genetics, diet and other factors, helicobacter pylori (H. pylori) had been regarded as a potential risk factor for hypertension in recent years. However, most studies had certain limitations and their results were inconsistent. Thus, it is necessary for us to assess the impact of H. pylori on hypertension through meta-analysis. Methods: We searched all published relevant literature through multiple databases by July 23, 2021. Pooled results were calculated under the random effect model. Heterogeneity was evaluated by the Q statistic and the I2 statistic. The risk of bias was evaluated via ROBINS-I tool. Publication bias was evaluated by the Egger test and Begg funnel plot. Results: 6 eligible studies involving 11317 hypertensive patients and 12765 controls were selected from 20767 retrieval records. Our research confirmed that H. pylori significantly increased the probability of suffering from hypertension in the random effect model (OR:1.34, 95% CI:1.10–1.63, P = 0.002, I2 = 74%). The same results were also found in both Asian population and developing country (OR:1.28, 95%CI:1.05–1.55, P = 0.003, I2 = 78.5%). Conclusions: Our results confirmed that H. pylori was a vital risk factor for hypertension. H. pylori-infected people were 13.4% higher risk for hypertension than uninfected individuals. In addition, it will be a new method to prevent and treat hypertension by eradicating H. pylori. Trial registration: The registration number for systematic review in PROSPERO CRD42021279677.Keywords
Funding Information
- Xiamen Medical and Health Guidance Project in 2020 (3502Z20209140)
- Xiamen Medical and Health Guidance Project in 2020 (3502Z20209141)
- Medical Innovation Project of Fujian Province (2019-CXB-37)
This publication has 46 references indexed in Scilit:
- Helicobacter pylori infection is identified as a cardiovascular risk factor in Central AfricansVascular Health and Risk Management, 2012
- Is Human Cytomegalovirus Infection Associated with Hypertension? The United States National Health and Nutrition Examination Survey 1999–2002PLOS ONE, 2012
- Possible role of salt intake in the development of essential hypertension*International Journal of Epidemiology, 2005
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Salt intake and Helicobacter pylori infectionJournal Of Hypertension, 2004
- Is there a relationship between helicobacter infection and blood pressure? Evidence from the community-based Bristol helicobacter projectGastroenterology, 2000
- Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosaGastroenterology, 1996
- Salty Food Intake and Risk of Helicobacter pylori InfectionJapanese Journal of Cancer Research, 1994
- Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.Journal of Clinical Pathology, 1994
- Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.Gut, 1991